Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

324 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
PRISM II: an open-label study to assess effectiveness of dextromethorphan/quinidine for pseudobulbar affect in patients with dementia, stroke or traumatic brain injury.
Hammond FM, Alexander DN, Cutler AJ, D'Amico S, Doody RS, Sauve W, Zorowitz RD, Davis CS, Shin P, Ledon F, Yonan C, Formella AE, Siffert J. Hammond FM, et al. BMC Neurol. 2016 Jun 9;16:89. doi: 10.1186/s12883-016-0609-0. BMC Neurol. 2016. PMID: 27276999 Free PMC article. Clinical Trial.
The relationship between extrapyramidal signs and cognitive performance in patients with Alzheimer's disease enrolled in the CERAD Study. Consortium to Establish a Registry for Alzheimer's Disease.
Clark CM, Ewbank D, Lerner A, Doody R, Henderson VW, Panisset M, Morris JC, Fillenbaum GG, Heyman A. Clark CM, et al. Neurology. 1997 Jul;49(1):70-5. doi: 10.1212/wnl.49.1.70. Neurology. 1997. PMID: 9222172 Clinical Trial.
Estrogen replacement therapy for treatment of mild to moderate Alzheimer disease: a randomized controlled trial. Alzheimer's Disease Cooperative Study.
Mulnard RA, Cotman CW, Kawas C, van Dyck CH, Sano M, Doody R, Koss E, Pfeiffer E, Jin S, Gamst A, Grundman M, Thomas R, Thal LJ. Mulnard RA, et al. JAMA. 2000 Feb 23;283(8):1007-15. doi: 10.1001/jama.283.8.1007. JAMA. 2000. PMID: 10697060 Clinical Trial.
A phase 2 multiple ascending dose trial of bapineuzumab in mild to moderate Alzheimer disease.
Salloway S, Sperling R, Gilman S, Fox NC, Blennow K, Raskind M, Sabbagh M, Honig LS, Doody R, van Dyck CH, Mulnard R, Barakos J, Gregg KM, Liu E, Lieberburg I, Schenk D, Black R, Grundman M; Bapineuzumab 201 Clinical Trial Investigators. Salloway S, et al. Neurology. 2009 Dec 15;73(24):2061-70. doi: 10.1212/WNL.0b013e3181c67808. Epub 2009 Nov 18. Neurology. 2009. PMID: 19923550 Free PMC article. Clinical Trial.
Donepezil preserves cognition and global function in patients with severe Alzheimer disease.
Black SE, Doody R, Li H, McRae T, Jambor KM, Xu Y, Sun Y, Perdomo CA, Richardson S. Black SE, et al. Neurology. 2007 Jul 31;69(5):459-69. doi: 10.1212/01.wnl.0000266627.96040.5a. Neurology. 2007. PMID: 17664405 Clinical Trial.
Donepezil in vascular dementia: a randomized, placebo-controlled study.
Wilkinson D, Doody R, Helme R, Taubman K, Mintzer J, Kertesz A, Pratt RD; Donepezil 308 Study Group. Wilkinson D, et al. Neurology. 2003 Aug 26;61(4):479-86. doi: 10.1212/01.wnl.0000078943.50032.fc. Neurology. 2003. PMID: 12939421 Clinical Trial.
Current concepts in mild cognitive impairment.
Petersen RC, Doody R, Kurz A, Mohs RC, Morris JC, Rabins PV, Ritchie K, Rossor M, Thal L, Winblad B. Petersen RC, et al. Arch Neurol. 2001 Dec;58(12):1985-92. doi: 10.1001/archneur.58.12.1985. Arch Neurol. 2001. PMID: 11735772 Review.
324 results
Jump to page
Feedback